HealthEquity posts profitable quarter as custodial revenue rises, buybacks and tech spend continue

Snapshot - HealthEquity, Inc. (NASDAQ: HQY): profitable quarter, growing custodial book, heavy buybacks and ongoing tech investment. Below are the facts from the Form 10‑Q and a concise read on what's happening inside.

Key facts & stats (as reported)
* Total revenue (three months ended July 31, 2025): $325,835 (in thousands) - up 9% YoY ($25,907).
* Total revenue (six months ended July 31, 2025): $656,679 (in thousands) - up 12% YoY ($69,154).
* Gross profit (quarter): $232,595 (in thousands).
* Net income (quarter): $59,854 (in thousands); diluted EPS $0.68 (quarter).
* Net income (six months): $113,769 (in thousands); diluted EPS $1.29 (six months).
* Adjusted EBITDA (quarter): $151,074 (in thousands) - 46% of revenue (vs 43% a year ago).
* Custodial revenue (quarter): $159,876 (in thousands) - +15% YoY; primary driver of revenue growth.
* Service revenue (quarter): $117,873 (in thousands) - +1% YoY.
* Interchange revenue (quarter): $48,086 (in thousands) - +8% YoY.
* Amortization of acquired intangible assets (quarter): $27,001 (in thousands).
* Technology & development expense (quarter): $64,804 (in thousands) - +11% YoY.
* Interest expense (quarter): $14,955 (in thousands); YTD interest expense $29,813 (in thousands).
* Income tax provision (quarter): $18,194 (in thousands) - effective tax rate 23.3% (quarter), 23.6% (six months).
* Cash & cash equivalents (July 31, 2025): $304,461 (in thousands).
* Total assets: $3,416,678 (in thousands).
* Long‑term debt, net (July 31, 2025): $1,006,834 (in thousands).
* Revolving credit facility outstanding: $411,875 (principal) as of July 31, 2025.
* Intangible assets, net: $1,152,456 (in thousands); Goodwill: $1,648,145 (in thousands).
* HSA metrics (as of July 31, 2025): HSAs administered 9,989 (in thousands), Total Accounts 17,142 (in thousands), Total HSA Assets $33,137 (in millions) (i.e., ~$33.1B).
* Stock repurchases: $125,810 (in thousands) used during six months ended July 31, 2025; $351.8M remaining authorization as of July 31, 2025.
* Treasury bond forwards notional: $1,250,000 (in thousands) - cash flow hedges; pre‑tax gains recognized in AOCI $273 (in thousands) for the quarter.

What's working (positives)
* Revenue and profitability are growing: revenue +9% YoY for the quarter and net income +67% YoY - clear top‑line growth with margin expansion (Adjusted EBITDA margins improved).
* Custodial business is the engine: custodial revenue jumped 15% YoY as HSA cash yields and balances increased; HSA Assets rose 12% YoY to ~$33.1B.
* Strong cash flow from operations: YTD operating cash provided $200,604 (in thousands), up from prior year - supports buybacks and debt paydown.
* Shareholder returns and capital allocation: active repurchase programs (used $125.8M in six months) while maintaining $304M in cash and paying down $50M principal on debt.
* Margin leverage from tech investments: service costs fell QoQ as technology efficiencies offset some volume growth, supporting higher Adjusted EBITDA.

Risks and negatives
* Rising and sizable operating investments: technology & development expense +11% YoY (quarter) - necessary but pressuring near‑term operating expense.
* Large amortization and intangible base: $1.15B intangibles (net) and $27.0M quarterly amortization reduce GAAP operating income and complicate comparisons.
* Material leverage: long‑term debt net ~$1.007B with $411.9M outstanding on the revolver - interest exposure if rates rise; YTD interest expense increased versus prior year.
* Heavy buybacks consume cash: $125.8M of cash used for repurchases in six months; continued repurchases could limit M&A or balance sheet flexibility if needed.
* Cybersecurity litigation/regulatory risk: company disclosed a cyber incident with consolidated class action and regulatory inquiries - potential for material future loss (no accrual recorded yet).
* Tax provision up: effective tax rate increased and tax provision rose materially (income tax provision $18.2M quarter; $35.2M YTD) - discrete items affecting rates.
* Derivative exposure and complexity: $1.25B notional Treasury forwards hedge future custodial transitions - hedging reduces rate risk but adds complexity and fair‑value volatility in AOCI.

Bottom line - HealthEquity is delivering profitable growth driven by custodian yields and account growth, with improved margins and strong operating cash flow. Management is returning capital via buybacks while investing heavily in technology. Monitor three items closely: (1) legal/cyber outcomes and regulatory exposure, (2) leverage and interest‑rate sensitivity given ~$1.0B net debt and revolver usage, and (3) the pace and ROI of technology spending versus margin gains. The income statement shows healthy revenue and net‑income momentum but also sizable non‑cash amortization, higher tech costs and tax/interest headwinds that can swing GAAP results.